TABLE 4.
n/N | Univariable analysis | Multivariable analysis | ||||
---|---|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | |||
Sex | Male | 44/323 | 1.00 | 0.3 | _ | |
Female | 63/559 | 0.81 (0.53–1.22) | _ | |||
Age group, years | 18–40 | 33/281 | 1.00 | 0.79 | _ | |
>40 | 74/598 | 1.06 (0.61–1.81) | _ | |||
WHO stage at presentation | I–II | 43/304 | 1.00 | 0.14 | _ | |
III–IV | 49/463 | 0.60 (0.36–1.01) | _ | |||
CD4 at ART initiation, cel/ul | <200 | 48/386 | 1.00 | 0.95 | _ | |
200+ | 18/153 | 0.98 (0.52–1.83) | _ | |||
Period of ART initiation, years | 1998–2013 | 53/481 | 1.00 | 0.39 | _ | |
2014–2019 | 45/347 | 1.20 (0.79–1.84) | _ | |||
ART line regimen initiation | 1st line | 76/688 | 1.00 | 0.36 | _ | |
2nd/3rd line | 18/130 | 1.29 (0.74–2.24) | _ |
Abbreviations: ART, antiretroviral treatment; CI, confidence interval; OR, odds ratio; WHO, World Health Organisation.